Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Accumulated Expenses (2016 - 2025)

Skinvisible's Accumulated Expenses history spans 16 years, with the latest figure at $3.2 million for Q3 2025.

  • For Q3 2025, Accumulated Expenses rose 21.63% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $3.2 million, up 21.63%, while the annual FY2024 figure was $2.8 million, 8.13% up from the prior year.
  • Accumulated Expenses for Q3 2025 was $3.2 million at Skinvisible, up from $3.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $3.2 million in Q3 2025 and bottomed at $1.1 million in Q1 2021.
  • The 5-year median for Accumulated Expenses is $2.3 million (2023), against an average of $2.2 million.
  • The largest annual shift saw Accumulated Expenses skyrocketed 81.99% in 2021 before it rose 6.83% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $1.5 million in 2021, then soared by 32.59% to $2.0 million in 2022, then soared by 31.69% to $2.6 million in 2023, then grew by 8.13% to $2.8 million in 2024, then rose by 15.37% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Accumulated Expenses are $3.2 million (Q3 2025), $3.1 million (Q2 2025), and $2.9 million (Q1 2025).